Pentachlorophenol

Pentachlorophenol

SCHEMBL3260733

Oc1c(Cl)c(Cl)c(Cl)c(Cl)c1Cl.P

nearest known ligand 0.91

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 8/20 0.91
TSHR P16473 7/20 0.91
HPGD P15428 7/20 0.91
ALDH1A1 P00352 3/20 0.91
MEN1 O00255 2/20 0.91
LMNA P02545 2/20 0.91
MAPT P10636 2/20 0.91
KMT2A Q03164 2/20 0.91
CYP1A2 P05177 4/20 0.50
CYP2C9 P11712 4/20 0.50
HIF1A Q16665 3/20 0.50
CASP1 P29466 1/20 0.47
CYP2C19 P33261 1/20 0.43
MAPK1 P28482 3/20 0.42
CYP3A4 P08684 5/20 0.40
USP2 O75604 1/20 0.40
TP53 P04637 1/20 0.40
GLA P06280 1/20 0.40
THRB P10828 1/20 0.40
ALOX15 P16050 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pentachlorophenol SCHEMBL10696385 0.96 HSD17B10 (0.83) HSD17B10TSHRHPGDALDH1A1MEN1
Pentachlorophenol SCHEMBL3064441 0.96 HSD17B10 (0.83) HSD17B10TSHRHPGDALDH1A1MEN1
Pentachlorophenol SCHEMBL1828360 0.96 HSD17B10 (0.83) HSD17B10TSHRHPGDALDH1A1MEN1
Pentachlorophenol SCHEMBL4689930 0.96 HSD17B10 (0.83) HSD17B10TSHRHPGDALDH1A1MEN1
Pentachlorophenol SCHEMBL10772816 0.96 HSD17B10 (0.83) HSD17B10TSHRHPGDALDH1A1MEN1
Pentachlorophenol SCHEMBL23121452 0.95 HSD17B10 (1.00) HSD17B10TSHRHPGDALDH1A1MEN1
Pentachlorophenol SCHEMBL1492 0.95 HSD17B10 (1.00) HSD17B10TSHRHPGDALDH1A1MEN1
Pentachlorophenol SCHEMBL1330735 0.95 HSD17B10 (1.00) HSD17B10TSHRHPGDALDH1A1MEN1
Perchlorobenzene SCHEMBL28269084 0.95 HSD17B10 (1.00) HSD17B10TSHRHPGDALDH1A1MEN1
Pentachlorophenol SCHEMBL5315995 0.95 HSD17B10 (1.00) HSD17B10TSHRHPGDALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101866751-A Temperature-resistant electrolyte for aluminum electrolysis and application thereof GUANGDONG FENGHUA AT HOLDING 2010-10-20 CN claimed
EP-0799016-A1 POLYMERIZABLE COMPOUNDS AND COMPOSITIONS DENTSPLY INTERNATIONAL, INC. (US) 1997-10-08 EP claimed
WO-1996019179-A1 POLYMERIZABLE COMPOUNDS AND COMPOSITIONS DENTSPLY INTERNATIONAL INC. (US) 1996-06-27 WO claimed
US-11918555-B2 Dicarboxylic acid esters for the treatment of diseases and conditions associated with phospholipase D toxin NEW FRONTIER LABS, LLC (US) 2024-03-05 US disclosed
US-11911358-B2 Dicarboxylic acid esters for inducing an analgesic effect NEW FRONTIER LABS, LLC 2024-02-27 US disclosed
EP-4262780-A1 DICARBOXYLIC ACID ESTERS FOR THE TREATMENT OF DISEASES AND CONDITIONS ASSOCIATED WITH PHOSPHOLIPASE D TOXIN New Frontier Labs, LLC (US) 2023-10-25 EP disclosed
EP-4262779-A1 DICARBOXYLIC ACID ESTERS FOR INDUCING AN ANALGESIC EFFECT New Frontier Labs, LLC (US) 2023-10-25 EP disclosed
WO-2022130288-A1 DICARBOXYLIC ACID ESTERS FOR INDUCING AN ANALGESIC EFFECT NEW FRONTIER LABS, LLC (US) 2022-06-23 WO disclosed
WO-2022130290-A1 DICARBOXYLIC ACID ESTERS FOR THE TREATMENT OF DISEASES AND CONDITIONS ASSOCIATED WITH PHOSPHOLIPASE D TOXIN NEW FRONTIER LABS, LLC (US) 2022-06-23 WO disclosed
US-20220184023-A1 DICARBOXYLIC ACID ESTERS FOR INDUCING AN ANALGESIC EFFECT NEW FRONTIER LABS, LLC 2022-06-16 US disclosed
US-20220184024-A1 DICARBOXYLIC ACID ESTERS FOR THE TREATMENT OF DISEASES AND CONDITIONS ASSOCIATED WITH PHOSPHOLIPASE D TOXIN NEW FRONTIER LABS, LLC 2022-06-16 US disclosed
CN-1147808-A Process for preparing 5, 6-dihydroxy-2-amino-1, 2, 3, 4-tetrahydronaphthalene derivatives CHIESI FARMA SPA (IT) 1997-04-16 CN disclosed
WO-1994014774-A1 A PROCESS FOR THE PREPARATION OF 2,3,5,6-TETRACHLOROPYRIDINE CHEMINOVA AGRO A/S (DK) 1994-07-07 WO disclosed
EP-0351856-A2 Thiazolo[5,4-b]azepine compounds Takeda Chemical Industries, Ltd. (JP) 1990-01-24 EP disclosed
EP-0069527-B1 CYSTINE DERIVATIVES RECORDATI S.A. CHEMICAL and PHARMACEUTICAL COMPANY (CH) 1985-08-21 EP disclosed
EP-0131400-A2 Metal salts of lower dialkylphosphorodithioic acids The Lubrizol Corporation (US) 1985-01-16 EP disclosed
EP-0061206-B1 6-AMINOPENICILLANIC ACID ESTERS AND THEIR USE FOR PRODUCING NEW AMPICILLIN ESTERS KANEBO, LTD. (JP) 1984-09-19 EP disclosed
EP-0118790-A1 Novel aroylimidazolones MERRELL DOW PHARMACEUTICALS INC. (US) 1984-09-19 EP disclosed
EP-0113658-A1 Process for the purification of acetylene polymers SHOWA DENKO KABUSHIKI KAISHA (JP) 1984-07-18 EP disclosed
EP-0042803-A1 Non-aqueous cell using a cathode comprising the reaction product of bismuth trioxide and molybdenum trioxide and an electrolyte based on 3-methyl-2-oxazolidone UNION CARBIDE CORPORATION (US) 1981-12-30 EP disclosed